ELK-003
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text css=".vc_custom_1747656706954{padding-bottom: 30px !important;}"] ELK-003 - an opthalmic solution for the treatment of corneal abrasions associated with epidermolysis bullosa [ninja_tables id="20545"] Investment summary Eliksa Therapeutics is developing ELK-003, a topical eye drop with the potential to both prevent and treat painful corneal...